DEF: U.S. Physical Therapy Announces 2025 Annual Meeting of Stockholders, Board Recommends Director Elections and Executive Pay Approval

U.S. Physical Therapy, Inc. will hold its 2025 Annual Meeting of Stockholders on May 20, 2025, with key proposals including the election of directors, an advisory vote on executive compensation, and ratification of the independent auditor appointment.

Summary

• U.S. Physical Therapy, Inc. is holding its Annual Meeting of Stockholders on May 20, 2025.
• The meeting will take place at 9:00 a.m. Central Time at the company's Houston headquarters.
• Stockholders will vote on three key proposals: electing eight directors, approving named executive officer compensation, and ratifying the appointment of Grant Thornton LLP as the independent auditor for 2025.
• The Board of Directors recommends voting in favor of all proposals.
• The record date for determining stockholders eligible to vote is March 25, 2025.
• As of the record date, 15,191,689 shares of common stock were outstanding.
• The Board has determined that six of the eight director nominees are independent under NYSE listing standards; Christopher J. Reading and Michael G. Mayrsohn are not considered independent.
• The company's executive compensation program includes base salary, annual cash incentives, long-term equity incentives, post-employment benefits, and other benefits and perquisites.
• The Compensation Committee uses peer group data as a reference point for compensation decisions.
• The company has adopted Officer and Director Share Ownership Guidelines to align the interests of executives and directors with shareholders.
• The company's ESG efforts are led internally by the company's ESG working group comprised of senior leaders from legal, operations, finance and human resources.
• The Board of Directors is overseeing the company's ESG efforts and receives periodic updates and reports on the efforts.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and factual manner. The board's recommendations are positive, but overall the sentiment is moderately positive due to the routine nature of the content.

Positives

• The Board of Directors is comprised of a majority of independent directors.
• The company has adopted a Clawback Policy for executive officers.
• The company has Officer and Director Share Ownership Guidelines to align interests with shareholders.
• The company is committed to enhancing Board diversity.
• The company is committed to serving patients, employees and communities in a sustainable and responsible manner.
• The company published an initial ESG Report detailing the ongoing process and philosophy regarding ESG.

Future Outlook

The Board believes that combining the roles of Chairman and Chief Executive Officer, along with the presence of a strong Lead Independent Director, is in the best interests of the Company and its stockholders to promote the pursuit for the Company's business objectives and strategic growth plans.

Management Comments

• The Board believes it is important to retain flexibility to allocate the responsibilities of Chairman of the Board and Chief Executive Officer in a manner that it believes is in the best interests of the Company and its stockholders.
• The Board continues to believe that Mr. Reading's service as both Chairman of the Board and Chief Executive Officer puts him in the best position to execute our business strategy and business plans to maximize shareholder value.

Industry Context

The document provides insight into the corporate governance practices, executive compensation strategies, and board composition of a publicly-traded healthcare company, U.S. Physical Therapy, Inc., which is relevant to understanding industry standards and trends in the healthcare services sector.

Comparison to Industry Standards

• The document benchmarks executive compensation against a peer group including Surgery Partners, Inc., ATI Physical Therapy, Inc., and Select Medical Corporation.
• The company's corporate governance practices, such as having a majority of independent directors and various board committees, align with NYSE listing standards and SEC regulations.
• The company's ESG reporting aligns with the Sustainability Accounting Standards Board (SASB) standards for the industry.

Management Changes

Corporate Governance

Related Party Transactions

• The Audit Committee reviewed two real estate leases involving Michael G. Mayrsohn, a director nominee, where one of the Company's subsidiaries leases clinic locations from entities owned by Mr. Mayrsohn.
• The leases involve annual rental payments of $150,000 and $330,000, respectively.
• A third-party valuation firm concluded that the leases were consistent with fair market value, and the Audit Committee determined that the leases contained terms and conditions consistent with fair market value.

Stakeholder Impact

• Shareholders are being asked to vote on key proposals that will impact the company's governance and executive compensation.
• Employees are impacted by the company's compensation policies and ESG initiatives.
• Patients benefit from the company's commitment to enhancing health and wellness in the communities it serves.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on May 20, 2025.
• The Compensation Committee will continue to consider the outcome of the company's say-on-pay proposals when making future compensation decisions for the NEOs.
• The Company continues to grow in our ESG journey and is committed to looking for ways to expand efforts and reporting, taking into account feedback from key stakeholders.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Executive Compensation, Director Election, Grant Thornton, Audit Committee, Corporate Governance, Stockholders, USPH, U.S. Physical Therapy